 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/12/2026 |
$26.84 |
$27.30 |
$26.11 |
$26.17 |
1.78M | | 08/13/2026 |
$26.00 |
$26.48 |
$25.88 |
$25.96 |
1.90M | | 08/14/2026 |
$25.73 |
$25.93 |
$25.30 |
$25.70 |
1.68M | | 08/17/2026 |
$25.90 |
$26.43 |
$25.30 |
$26.15 |
1.32M | | 08/18/2026 |
$25.88 |
$26.31 |
$25.46 |
$26.00 |
1.90M |
 |
| Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). | |
 |

Dyne Therapeutics (DYN) has the following price history information. Looking back at DYN historical stock prices for the last five trading days, on August 12, 2026, DYN opened at $26.84, traded as high as $27.30 and as low as $26.11, and closed at $26.17. Trading volume was a total of 1.78M shares. On August 13, 2026, DYN opened at $26.00, traded as high as $26.48 and as low as $25.88, and closed at $25.96. Trading volume was a total of 1.90M shares. On August 14, 2026, DYN opened at $25.73, traded as high as $25.93 and as low as $25.30, and closed at $25.70. Trading volume was a total of 1.68M shares. On August 17, 2026, DYN opened at $25.90, traded as high as $26.43 and as low as $25.30, and closed at $26.15. Trading volume was a total of 1.32M shares. On August 18, 2026, DYN opened at $25.88, traded as high as $26.31 and as low as $25.46, and closed at $26.00. Trading volume was a total of 1.90M shares.
DYN Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Dyne Therapeutics shares, starting with a $10,000 purchase of DYN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/17/2020 |
|
| End date: |
08/18/2026 |
|
| Start price/share: |
$23.90 |
|
| End price/share: |
$26.00 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
8.79% |
|
| Average Annual Total Return: |
1.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$10,876.99 |
|
| Years: |
5.92 |
|
|
 |
| Date |
Close |
| 08/12/2026 | $26.17 | | 08/13/2026 | $25.96 | | 08/14/2026 | $25.70 | | 08/17/2026 | $26.15 | | 08/18/2026 | $26.00 |
|
 |